Skip to main content
SpringerLink
Log in

Épidémiologie, facteurs de risque, dépistage des cancers broncho-pulmonaires

  • Chapter
Oncologie thoracique

Part of the book series: Oncologie pratique ((ONCOLPRAT))

  • 391 Accesses

Résumé

Les cancers du poumon sont les plus répandus dans le monde avec 900 000 nouveaux cas par an chez l’homme et 330 000 nouveaux cas par an chez la femme. En France, quatre cancers concernent à eux seuls 50 % des patients : les cancers du sein, du poumon, les cancers colorectaux et de la prostate (fig. 1). Toujours en France, en 2005, on estime que 30651 nouveaux cas de cancers du poumon ont été diagnostiqués, dont 78 % chez l’homme. Cette même année, on estime qu’il a été à l’origine de 26624 décès (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Atlas de la mortalité par cancer en france métropolitaine. Évolution 1970–2004. Institut National du Cancer 2008

    Google Scholar 

  2. Bray F, Tyczynski JE, Parkin DM (2004) Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer 40: 96–125

    Article  PubMed  CAS  Google Scholar 

  3. Jemal A, Siegel R, Ward E et al. (2008) Cancer statistics, 2008. Cancer J Clin 58: 71–96

    Article  Google Scholar 

  4. Navada S, Lai P, Schwartz AG, Kalemkerian GP (2006). Temporal trends in small cell lung cancer: analysis of the national Surveillance Epidemiology and End-Results (SEER) database [abstract 7082]. J Clin Oncol 24(18S) (suppl): 384S

    Google Scholar 

  5. Alberg AJ, Ford JG, Samet JM (2007) American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest. 132(3 Suppl): 29S–55S

    Article  PubMed  CAS  Google Scholar 

  6. Doll R, Hill AB ( 1950) Smoking and carcinoma of the lung. Preliminary report. Br Med J 2: 739–748

    Article  PubMed  CAS  Google Scholar 

  7. Yang P, Allen MS, Aubry MC et al. (2005) Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128: 452–462

    Article  PubMed  Google Scholar 

  8. Zhang H, Cai B (2003) The impact of tobacco on lung health in China. Respirology 8: 17–21

    Article  PubMed  Google Scholar 

  9. Jemal A, Cokkinides VE, Shafey O et al. (2003) Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States). Cancer Causes Control 14: 579–585

    Article  PubMed  Google Scholar 

  10. Hirayama T (1981) Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. BMJ (Clin Res Ed) 282: 183–185

    Article  CAS  Google Scholar 

  11. Boffetta P (2002) Involuntary smoking and lung cancer. Scand J Work Environ Health 28(suppl): 30–40

    PubMed  CAS  Google Scholar 

  12. Gray A, Read S, McGale P, Darby S (2009) Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. Br Med J 338: a3110

    Article  Google Scholar 

  13. Darby SC, Whitley E, Howe GR et al. (1995) Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst 87: 378–384

    Article  PubMed  CAS  Google Scholar 

  14. Vineis P, Thomas T, Hayes RB (1988) Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer 42: 851–856

    PubMed  CAS  Google Scholar 

  15. Lernen RA, Dement JM, Wagoner JK (1980) Epidemiology of asbestos-related diseases. Environ Health Perspect 34: 1–11

    Article  Google Scholar 

  16. Cohen AJ, Higgins MW (1995) Health effects of diesel exhaust: epidemiology diesel exhaust: a critical analysis of emissions, exposure, and health effects; a special report of the Institute’s Working Group. 251-92 Health Effects Institute. Cambridge, MA

    Google Scholar 

  17. Smith AH, Lopipero PA, Barroga VR (1995) Meta-analysis of studies of lung cancer among silicotics. Epidemiology 6: 617–662

    Article  PubMed  CAS  Google Scholar 

  18. Vineis P, Forastiere F, Hoek G et al. (2004) Outdoor air pollution and lung cancer: recent epidemiologic evidence. Int J Cancer 111: 647–652

    Article  PubMed  CAS  Google Scholar 

  19. Dockery DW, Pope CA, Xu X et al. (1993) An association between air pollution and mortality in six US cities. N Engl J Med 329: 1753–1759

    Article  PubMed  CAS  Google Scholar 

  20. Miller AB, Altenburg HP, Bueno-de-Mesquita B et al. (2004) Fruits and vegetables and lung cancer: findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 108: 269–276

    Article  PubMed  CAS  Google Scholar 

  21. Schwartz AG, Yang P, Swanson GM (1996) Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144: 554–562

    PubMed  CAS  Google Scholar 

  22. Sone S, Li F, Yang ZG, Honda T et al. (2001) Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 84: 25–32

    Article  PubMed  CAS  Google Scholar 

  23. Sobue T, Moriyama N, Kaneko M et al. (2002) Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 20: 911–920

    Article  PubMed  Google Scholar 

  24. Nawa T, Nakagawa T, Kusano S et al. (2002) Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 122: 15–20

    Article  PubMed  Google Scholar 

  25. Frost J, Ball WC, Levin M et al. ( 1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. Am Rev Respir Dis 130: 549–554

    PubMed  CAS  Google Scholar 

  26. Tockman MS (1986) Lung cancer screening: the Johns Hopkins study. Chest 89(suppl): 324–334

    Article  Google Scholar 

  27. Melamed MR (2000) Lung cancer screening results in the National Cancer Institute New York study. Cancer 89: 2356–2362

    Article  PubMed  CAS  Google Scholar 

  28. Fontana R, Sanderson DR, Woolner LB et al. (1986) Lung cancer screening: the Mayo program. J Occup Med 28: 746–750

    Article  PubMed  CAS  Google Scholar 

  29. Marcus PM, Bergstralh EJ, Fagerstrom RM et al. (2000) Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 92: 1308–1316

    Article  PubMed  CAS  Google Scholar 

  30. Kubik AK, Parkin DM, Zatloukal P (2000) Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 89: 2363–2368

    Article  PubMed  CAS  Google Scholar 

  31. Prorok PC, Andriole GL, Bresalier RS et al. (2000) Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trial 21: 273S–309S

    Article  CAS  Google Scholar 

  32. Henschke CI, McCauley DI, Yankelevitz DF et al. (1999) Early lung cancer action project: overall design and findings from baseline screening. Lancet 354: 99–105

    Article  PubMed  CAS  Google Scholar 

  33. Swenson SJ, Jett JR, Sloan JA et al. (2002) Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 165: 433–434

    Google Scholar 

  34. Diederich S, Wormanns D, Semik M et al. (2002) Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 222: 773–781

    Article  PubMed  Google Scholar 

  35. Blanchon T, Bréchot JM, Grenier PA et al. (2007) Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58: 50–58

    Article  PubMed  Google Scholar 

  36. Henschke CI, Yankelevitz DF, Libby DM et al. (2006) International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355: 1763–1771

    Article  PubMed  Google Scholar 

  37. Bach PB, Jett JR, Pastorino U (2007) Computed tomography screening and lung cancer outcomes. JAMA 297: 953–961

    Article  PubMed  CAS  Google Scholar 

  38. Granville CA, Dennis PA (2005) An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 32: 169–176

    Article  PubMed  CAS  Google Scholar 

  39. Yanagisawa K, Shyr Y, Xu BJ, Massion PP et al. (2003) Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362: 433–439

    Article  PubMed  CAS  Google Scholar 

  40. Rahman SM, Shyr Y, Yildiz PB et al. (2005) Proteomic patterns of preinvasive lesions. Am J Respir Crit Care Med 172: 1556–1562

    Article  PubMed  Google Scholar 

  41. Yildiz PB, Shyr Y, Rahman JS, Wardwell NR et al. (2007) Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 10: 893–901

    Article  Google Scholar 

  42. Showe MK,V achani A, Kossenkov AV et al. (2009). Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non small cell lung cancer from patients with nonmalignant lung disease. Cancer Res. 69; 9202–9210

    Article  PubMed  CAS  Google Scholar 

  43. Guber A, Greif J, Rona A et al. (2010). Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection. Cancer Cytopathol [Epub ahead of print]

    Google Scholar 

  44. Magee ND, Gray RD, Imrie M et al. (2008). SELDI-TOF analysis of induced sputum in the diagnosis of lung cancer. Am J Respir Crit Care Med 177: A561

    Google Scholar 

  45. Breault D, Subramanian H, Ray D et al. (2008). Bio-Optical Assessment of Buccal Mucosa: A Novel Risk Marker for Lung Cancer. Am J Respir Crit Care Med 177: A560

    Google Scholar 

  46. Gurjar RS, Backman V, Perelman LT et al. (2001) Imaging human epithelial properties with polarized light-scattering spectroscopy. Nat Med 7: 1245–1248

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de pneumologie, CHU de Tours, INSERM U618, IFR 135, 37044, Tours Cedex

    E. Lemarié

Authors
  1. E. Lemarié
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France

About this chapter

Cite this chapter

Lemarié, E. (2011). Épidémiologie, facteurs de risque, dépistage des cancers broncho-pulmonaires. In: Oncologie thoracique. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-99041-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-99041-0_2

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-99040-3

  • Online ISBN: 978-2-287-99041-0

Publish with us

Policies and ethics

Search

Navigation